Contemporary use of SGLT2 inhibitors in heart failure patients with diabetes mellitus: a comparison of DPP4 inhibitors in a nationwide electric health database of the superaged society

BACKGROUND: There is a lack of recent data reflecting the actual use of sodium-glucose cotransporter-2 (SGLT2) inhibitors for heart failure (HF) and type 2 diabetes (DM) in the superaged society. The present study investigated the association between the use of SGLT2 inhibitors and one-year prognosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakai, Michikazu, Iwanaga, Yoshitaka, Kanaoka, Koshiro, Sumita, Yoko, Nishioka, Yuichi, Myojin, Tomoya, Kubo, Shinichiro, Okada, Katsuki, Soeda, Tsunenari, Noda, Tatsuya, Sakata, Yasushi, Imamura, Tomoaki, Saito, Yoshihiko, Yasuda, Satoshi, Miyamoto, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375946/
https://www.ncbi.nlm.nih.gov/pubmed/35964039
http://dx.doi.org/10.1186/s12933-022-01586-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375946/
https://www.ncbi.nlm.nih.gov/pubmed/35964039
http://dx.doi.org/10.1186/s12933-022-01586-6

Ejemplares similares